India is witnessing a silent epidemic of non-alcoholic fatty liver disease. A new set of guidelines have been released by the Asian Pacific Association for the Study of the Liver (APASL). The ...
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
Galecto, Inc. focuses on oncology and liver diseases, acquiring global rights to GB3226 for AML development and ongoing clinical trials. Galecto, Inc., a biotechnology company focused on ...
Metabolic-dysfunction-associated steatotic liver disease (MASLD) arises from excessive intrahepatic triglyceride accumulation ...
When an organ is injured, our body initiates a healing process. If the injury is repeated or chronic, it can lead to an ...
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the ...
Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic fatty liver diseases (NAFLD) into more severe forms of liver disease by ...
Focus on the gut-liver axis: Semisynthetic bile acid has anti-inflammatory effects on the gut. ScienceDaily . Retrieved March 18, 2025 from www.sciencedaily.com / releases / 2025 / 03 ...